Abstract: The present invention relates to a composition for preventing or treating transplantation rejection or a transplantation rejection disease, comprising a novel compound and a calcineurin inhibitor. A co-administration of the present invention 1) reduces the activity of pathogenic Th1 cells or Th17 cells, 2) increases the activity of Treg cells, 3) has an inhibitory effect against side effects, such as tissue damage, occurring in the sole administration thereof, 4) inhibits various pathogenic pathways, 5) inhibits the cell death of inflammatory cells, and 6) increases the activity of mitochondria, in an in vivo or in vitro allogenic model, a transplantation rejection disease model, a skin transplantation model, and a liver-transplanted patient, and thus inhibits transplantation rejection along with mitigating side effects possibly occurring in the administration of a conventional immunosuppressant alone.

Abstract: A data mining device, and a speech recognition method and system using the same are disclosed. The speech recognition method includes selecting speech data including a dialect from speech data, analyzing and refining the speech data including a dialect, and learning an acoustic model and a language model through an artificial intelligence (AI) algorithm using the refined speech data including a dialect. The user is able to use a dialect speech recognition service which is improved using services such as eMBB, URLLC, or mMTC of 5G mobile communications.

Abstract: A data mining device, and a speech recognition method and system using the same are disclosed. The speech recognition method includes selecting speech data including a dialect from speech data, analyzing and refining the speech data including a dialect, and learning an acoustic model and a language model through an artificial intelligence (AI) algorithm using the refined speech data including a dialect. The user is able to use a dialect speech recognition service which is improved using services such as eMBB, URLLC, or mMTC of 5G mobile communications.

Abstract: The present invention relates to a skin anti-aging composition containing Irilin B (5,7,2?-trihydroxy-6-methoxyisoflavone) or a salt thereof, wherein Irilin B isolated from Salicornia spp. may be used itself or in the form of a salt thereof, and shows effects of enhancing skin elasticity, preventing and reducing wrinkles, or maintaining skin moisturization. The skin anti-aging composition of the present invention can be prepared in various forms, such as a cosmetic composition, a food composition, a feed composition, or a pharmaceutical composition.

Abstract: Disclosed are a regional dialect phoneme adaptive training method and system. The regional dialect phoneme adaptive training method includes transcription of text data, and generation of a regional dialect corpus based on the text data and regional dialect-containing speech data, and generation of an acoustic model and a language model using the regional dialect corpus. The generation of an acoustic model and a language model may be performed by machine learning of an artificial intelligence (AI) algorithm in which phonemes of a regional dialect item and a frequency of the phonemes of the regional dialect item are extracted and used. A user is able to use a regional dialect speech recognition service which is improved using 5G mobile communication technologies of eMBB, URLLC, or mMTC.

Abstract: Disclosed are a speech data based language modeling system and method. The speech data based language modeling method includes transcription of text data, and generation of a regional dialect corpus based on the text data and regional dialect-containing speech data and generation of an acoustic model and a language model using the regional dialect corpus. The generation of an acoustic model and a language model is performed by machine learning of an artificial intelligence (AI) algorithm using speech data and marking of word spacing of a regional dialect sentence using a speech data tag. A user is able to use a regional dialect speech recognition service which is improved using 5G mobile communication technologies of eMBB, URLLC, or mMTC.

Abstract: The present invention relates to a pharmaceutical composition comprising an acanthoside B compound as an effective ingredient for preventing or treating dementia or for improving a cognitive function. In the present invention, a desalted glasswort extract, and acanthoside B, which is isolated from the extract and acts as an effective ingredient inhibitory of acetylcholine esterase, were found to have an excellent neuroprotective activity through the inhibition of neuroinflammation and to improve memory retention and remarkably enhance spatial cognitive ability as measured by passive avoidance test and Y-maze test in a scopolamine-induced amnesic animal model. The acanthoside B or glasswort extract of the present invention can be applied to a pharmaceutical composition for preventing or treating dementia, a pharmaceutical composition for improving a cognitive function, or a health functional food or feed for improving memory retention and cognitive function.

Abstract: The present invention relates to a pharmaceutical composition comprising an acanthoside B compound as an effective ingredient for preventing or treating dementia or for improving a cognitive function. In the present invention, a desalted glasswort extract, and acanthoside B, which is isolated from the extract and acts as an effective ingredient inhibitory of acetylcholine esterase, were found to have an excellent neuroprotective activity through the inhibition of neuroinflammation and to improve memory retention and remarkably enhance spatial cognitive ability as measured by passive avoidance test and Y-maze test in a scopolamine-induced amnesic animal model. The acanthoside B or glasswort extract of the present invention can be applied to a pharmaceutical composition for preventing or treating dementia, a pharmaceutical composition for improving a cognitive function, or a health functional food or feed for improving memory retention and cognitive function.

Abstract: Disclosed are a regional dialect phoneme adaptive training method and system. The regional dialect phoneme adaptive training method includes transcription of text data, and generation of a regional dialect corpus based on the text data and regional dialect-containing speech data, and generation of an acoustic model and a language model using the regional dialect corpus. The generation of an acoustic model and a language model may be performed by machine learning of an artificial intelligence (AI) algorithm in which phonemes of a regional dialect item and a frequency of the phonemes of the regional dialect item are extracted and used. A user is able to use a regional dialect speech recognition service which is improved using 5G mobile communication technologies of eMBB, URLLC, or mMTC.

Abstract: Disclosed are a speech data based language modeling system and method. The speech data based language modeling method includes transcription of text data, and generation of a regional dialect corpus based on the text data and regional dialect-containing speech data and generation of an acoustic model and a language model using the regional dialect corpus. The generation of an acoustic model and a language model is performed by machine learning of an artificial intelligence (AI) algorithm using speech data and marking of word spacing of a regional dialect sentence using a speech data tag. A user is able to use a regional dialect speech recognition service which is improved using 5G mobile communication technologies of eMBB, URLLC, or mMTC.

Abstract: The present invention relates to a pharmaceutical composition comprising an acanthoside B compound as an effective ingredient for preventing or treating dementia or for improving a cognitive function. In the present invention, a desalted glasswort extract, and acanthoside B, which is isolated from the extract and acts as an effective ingredient inhibitory of acetylcholine esterase, were found to have an excellent neuroprotective activity through the inhibition of neuroinflammation and to improve memory retention and remarkably enhance spatial cognitive ability as measured by passive avoidance test and Y-maze test in a scopolamine-induced amnesic animal model. The acanthoside B or glasswort extract of the present invention can be applied to a pharmaceutical composition for preventing or treating dementia, a pharmaceutical composition for improving a cognitive function, or a health functional food or feed for improving memory retention and cognitive function.

Abstract: Disclosed are a functionally reinforced desalted nutritional composition, a desalted extract and a cold-water-extracted salt substitute, which are derived from halophytes that grow in coastal regions under highly saline conditions and thus retain high salt concentrations, as well as the use of the desalted nutritional composition for combating obesity.

Abstract: An apparatus and method that generate a trigger signal required for side channel analysis by analyzing the data of a smart card cryptographic module in real time. In the trigger signal generation method, a data input/output signal of a cryptographic module is monitored in real time. A preset section in the data input/output signal is analyzed. A reference signal is generated using the data input/output signal and a signal obtained from results of analysis of the preset section, and a trigger signal is generated using the reference signal.

Abstract: The present invention relates to an apparatus and method for acquiring noise source entropy for a random number generator, which use contention for access to memory between Graphical Processing Unit (GPU) cores. For this, an apparatus for acquiring noise source entropy for a random number generator includes a core calling unit for simultaneously calling a plurality of cores to a critical area, and a noise source entropy generation unit for generating noise source entropy based on a sequence of entry of the plurality of cores into the critical area.

Abstract: A journaling method is provided for supporting a recovery when a system is abnormally terminated in a shared disk environment. When a system call operation to take part in a journaling is generated, in order to guarantee a recovery, a transaction is started and new transaction region is assigned. Then, a system is initialized and a transaction type is set up. Lock information on modified data is acquired and added to the transaction so that a transaction manages lock information. A reflection to a disk during a modification of metadata is prevented. Modified metadata added to the transaction and modified information on principal general data are recorded. Then, lock information connected to the transaction is released.

Abstract: A journaling method is provided for supporting a recovery when a system is abnormally terminated in a shared disk environment. When a system call operation to take part in a journaling is generated, in order to guarantee a recovery, a transaction is started and new transaction region is assigned. Then, a system is initialized and a transaction type is set up. Lock information on modified data is acquired and added to the transaction so that a transaction manages lock information. A reflection to a disk during a modification of metadata is prevented. Modified metadata added to the transaction and modified information on principal general data are recorded. Then, lock information connected to the transaction is released.